Company profile for Allergy Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Allergy Therapeutics Limited (ATL) is a speciality biopharmaceutical company. It has two sterile manufacturing facilities licensed and regulated by the MHRA.Manufacturing systems and processes employed by ATL are highly flexible and adaptable with batch sizes ranging from 0.5 to 150 Litres. We have the capability to fill abroad range of vial and bottles and Readyfill Pre-Filled Syringes and have a highly flexible parenteral in...
Allergy Therapeutics Limited (ATL) is a speciality biopharmaceutical company. It has two sterile manufacturing facilities licensed and regulated by the MHRA.Manufacturing systems and processes employed by ATL are highly flexible and adaptable with batch sizes ranging from 0.5 to 150 Litres. We have the capability to fill abroad range of vial and bottles and Readyfill Pre-Filled Syringes and have a highly flexible parenteral inspection and packaging capability.Our academic base is strong in the fields of Immunology, Biology, Microbiology, Chemistry and Biochemistry with a wide scope in qualifications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Ki...
Telephone
Telephone
44 190 384 5849
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/agc-to-use-recently-expanded-germany-site-for-peanut-allergy-drug-trials/

J. Sullivan ENDPTS
01 Apr 2022

https://www.agcbio.com/news/allergy-therapeutics-selects-agc-biologics-to-manufacture-novel-peanut-allergy-vaccine-candidate

PRESS RELEASE
31 Mar 2022

https://www.globenewswire.com/news-release/2022/01/26/2373343/0/en/Allergy-Therapeutics-announces-FDA-clearance-of-IND-application-for-novel-peanut-allergy-vaccine-candidate-VLP-Peanut.html

GLOBENEWSWIRE
26 Jan 2022

https://www.investegate.co.uk/allergy-therapeutics--agy-/rns/secondary-endpoints-from-vlp-peanut-001/202109130700074838L/

INVESTEGATE
13 Sep 2021

https://www.investegate.co.uk/allergy-therapeutics--agy-/rns/successful-primary-outcome-of-vlp-peanut-001/202108030700073254H/

INVESTEGATE
03 Aug 2021

https://www.directorstalkinterviews.com/allergy-therapeutics-announces-completion-of-treatment-phase-in-innovative-g309-exploratory-field-study/412985692

DIRECTORSTALKINTERVIEWS
06 May 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty